[
  {
    "date": "2023-12-30",
    "symbol": "BGLC",
    "period": "FY",
    "entityregistrantname": "BIONEXUS GENE LAB CORP",
    "entitycentralindexkey": 1737523,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "2023-12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2023,
    "entityextransitionperiod": "false",
    "entitycommonstocksharesoutstanding": 17667663,
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityfilenumber": "333-269753",
    "entityincorporationstatecountrycode": "WY",
    "entitytaxidentificationnumber": "35-2604830",
    "entityaddressaddressline1": "Unit 02, Level 10, Tower B, Avenue 3, The Vertical",
    "entityaddressaddressline2": "Business Suite II, Bangsar South",
    "entityaddressaddressline3": "8 Jalan Kerinchi",
    "entityaddresscityortown": "Kuala Lumpur",
    "entityaddresscountry": "MY",
    "entityaddresspostalzipcode": 59200,
    "cityareacode": 307,
    "icfrauditorattestationflag": "false",
    "localphonenumber": "241 6898",
    "security12btitle": "Common Stock, no par value",
    "tradingsymbol": "BGLC",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "auditorname": "JP CENTURION & PARTNERS PLT",
    "auditorlocation": "Kuala Lumpur, Malaysia",
    "auditorfirmid": 6723,
    "cash": 2623965,
    "depositsassets": 3305371,
    "accountsreceivablenet": 799674,
    "otherreceivables": 122432,
    "incometaxesreceivable": 57588,
    "inventorynet": 1137770,
    "assetscurrent": 8046800,
    "operatingleaserightofuseasset": 141544,
    "propertyplantandequipmentnet": 1511618,
    "otherinvestments": 1699831,
    "assetsnoncurrent": 3352993,
    "assets": 11399793,
    "accountspayablecurrent": 1402180,
    "otheraccountspayableandaccruedliabilities": 180912,
    "operatingleaseliabilitycurrent": 34632,
    "amountowingtodirector": 13199,
    "liabilitiescurrent": 1630923,
    "operatingleaseliabilitynoncurrent": 98763,
    "deferredincometaxliabilitiesnet": 12255,
    "liabilitiesnoncurrent": 111018,
    "liabilities": 1741941,
    "commonstockvalue": 17191315,
    "additionalpaidincapital": -5011891,
    "retainedearningsaccumulateddeficit": -1844278,
    "accumulatedothercomprehensiveincomelossnetoftax": -677294,
    "stockholdersequity": 9657852,
    "liabilitiesandstockholdersequity": 11399793,
    "commonstocksharesauthorized": 300000000,
    "commonstocksharesoutstanding": 17667663,
    "preferredstocksharesauthorized": 30000000,
    "revenues": 9770806,
    "costofrevenue": 8441308,
    "grossprofit": 1329498,
    "otherincome": 486036,
    "generalandadministrativeexpense": 4409122,
    "operatingincomeloss": -2593588,
    "financecosts": -13929,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -2607517,
    "deferredothertaxexpensebenefit": 17359,
    "incometaxespaid": 38885,
    "incometaxexpensebenefit": -21526,
    "netincomeloss": -2629043,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletoparent": -268232,
    "comprehensiveincomenetoftax": -2897275,
    "earningpersharebasicanddiluted": -0.183,
    "weightedaveragenumberofcommonsharesoutstandingbasicanddiluted": 15875455,
    "sharesissued": 17667663,
    "stockissuedduringperiodsharesnewissues": 1044351,
    "stockissuedduringperiodvaluenewissues": 1046,
    "foreigncurrencytranslationloss": -268232,
    "impactsarisingfromapplicationoftopic": -371627,
    "stockissuedduringperiodsharesnewissuesone": 1437500,
    "stockissuedduringperiodvaluenewissuesone": 5750000,
    "stockissuedduringperiodsharesnewissuestwo": 709299,
    "stockissuedduringperiodvaluenewissuestwo": 510695,
    "profitloss": -2629043,
    "financeleaserightofuseassetamortization": 25170,
    "allowanceforloanandleaselosseswriteoffs": 942800,
    "provisionfordoubtfulaccounts": 6261,
    "depreciation": 83253,
    "dividendincome": -61409,
    "fairvalueassetsmeasuredonrecurringbasischangeinunrealizedgainloss": -313859,
    "paymentstoacquireotherinvestments": 6194,
    "interestincomeexpensenet": 8877,
    "paymentstoacquirepropertyplantandequipment": 18,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 511740,
    "inventorywritedown": 424,
    "operatinglossprofitbeforeworkingcapitalchanges": -1419574,
    "increasedecreaseininventories": -160387,
    "increasedecreaseinotherreceivables": 650810,
    "increasedecreaseinotheraccountspayable": -381293,
    "increasedecreaseincustomeradvances": -23123,
    "increasedecreaseinoperatingleaseliability": 76620,
    "increasedecreaseinincometaxesreceivable": -44648,
    "netcashprovidedbyusedinoperatingactivities": -1301595,
    "paymentstoacquirecommercialrealestate": 320733,
    "proceedsfromequitymethodinvestmentdividendsordistributionsreturnofcapital": 61409,
    "paymentstoacquirepropertyplantandequipments": 149398,
    "proceedsfromsaleofotherinvestments": 26146,
    "netcashprovidedbyusedininvestingactivities": -382576,
    "paymentstominorityshareholders": 8877,
    "repaymentstodirectors": 13199,
    "repaymentofsharessubscriptions": 5750000,
    "netcashprovidedbyusedinfinancingactivities": 5754322,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -259679,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 3810472,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 5929336,
    "fixeddepositsplacedwithfinancialinstitutions": 3305371,
    "cashandbankbalances": 2623965,
    "cashandcashequivalentsendoffinancialyear": 5929336,
    "interestpaid": 13929,
    "proceedsfromincometaxrefunds": 312,
    "incometaxespaidnet": -66973,
    "businessacquisitiondescriptionofacquiredentity": "The principal office address is Unit 02 Level 10, Tower B, Vertical Business Suite, No. 8 Jalan Kerinchi, Bangsar South, 59200 Kuala Lumpur, Malaysia, our lab is located at Lab 353, Chemical Science Centre, University Science Malaysia, George Town, Penang, Malaysia. We also have a blood collection center located at 1st floor, Lifecare Medical Centre, Kuala Lumpur, Malaysia",
    "businessacquisitioneffectivedateofacquisition1": "2017-08-23",
    "businessacquisitionequityinterestsissuedorissuablenumberofsharesissued": 68487261,
    "principalannualratesexpectedusefullife": 0.2,
    "yearendusmyrexchangerate": 4.59,
    "yearlyaverageusmyrexchangerate": 4.5658,
    "impactsarisingfromapplicationtradereceivables": -371627,
    "impactsarisingfromapplicationretainedearnings": -371627,
    "restated": 2496737,
    "tradereceivablesheldforsalenetnotpartofdisposalgroup": 2107182,
    "securitiesborrowedallowanceforcreditloss": 1314427,
    "fairvalueoptionaggregatedifferencesloansandlongtermreceivables": -6919,
    "tradeandloansreceivablesheldforsalenetnotpartofdisposalgroup": 799674,
    "impactsarisingfromapplicationtradereceivablesallowance": 371627,
    "tradereceivablesallowancerestarted": 371627,
    "chargeforthetradereceivablesyear": 942800,
    "tradereceivablesallowanceendofperiod": 1307508,
    "tradereceivablesdescription": "From July 2023 onwards, Chemrex had increased the interest to 8.4%. Chemrex imposed 6% per annum interest on Mawintech Sdn Bhd since May 2021 till to date. The normal trade credit term is generally on 30 days to 90 days term",
    "taxrecoverable": -57588,
    "deferredtaxliabilities": 12255,
    "incometaxsliability": -45333,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.15,
    "additionofrightofuseliabilities": 113279,
    "accumulatedamortizationoflease": -25038,
    "foreigntranslationdifferences": -2428,
    "operatingleaseliability": 133395,
    "addadditionofleaseliabilities": 113279,
    "operatingleasepayments": 39798,
    "addimputedinterest": 5613,
    "otherliabilitiescurrent": 34632,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 34632,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 30304,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 32353,
    "operatingleasesfutureminimumpaymentsdueinfiveyears": 22361,
    "operatingleasesfutureminimumpaymentsdueinsixyear": 13745,
    "operatingleasesfutureminimumpaymentsdue": 133395,
    "operatingcashflowfromoperatinglease": 76620,
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 141544,
    "finitelivedintangiblesassetusefullife": "P4Y6M",
    "weightedaveragediscountrateforoperatinglease": 0.0653,
    "discountpercentagerateeffectivedate": 0.064,
    "discountpercentagerateinitialrecognizeddate": 0.0665,
    "operatingleaseexpense": 5613,
    "operatingleaserightofuseassetamortizationexpense": 25170,
    "propertyplantandequipmentgross": 1124,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 659115,
    "addforeigntranslationdifferences": -225889,
    "otherinvestmentsbeginningbalance": 1150898,
    "additionduringtheyear": 320733,
    "disposalgroupnotdiscontinuedoperationgainlossondisposal": -26146,
    "fairvalueloss": 313859,
    "impairmentonotherinvestment": -6194,
    "foreignexchangetranslation": -53319,
    "otherinvestmentseningbalance": 1699831,
    "concentrationriskpurchase": 1467381,
    "concentrationriskpercentage1": 0.1,
    "concentrationofriskaccountspayabletrade": 252435,
    "commonstocksharesissued": 17667663,
    "othergeneralandadministrativeexpense": 245747,
    "interestexpense": 5052
  },
  {
    "date": "2022-12-30",
    "symbol": "BGLC",
    "period": "FY",
    "entityregistrantname": "BIONEXUS GENE LAB CORP",
    "entitycentralindexkey": 1737523,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "2022-12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "entityextransitionperiod": "false",
    "entitypublicfloat": 48487449,
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "333-269753",
    "entityincorporationstatecountrycode": "WY",
    "entitytaxidentificationnumber": "35-2604830",
    "entityinteractivedatacurrent": "Yes",
    "entityaddressaddressline1": "Unit 02, Level 10, Tower B, Avenue 3, The Vertical",
    "entityaddressaddressline2": "Business Suite II, Bangsar South",
    "entityaddresscityortown": "Kuala Lumpur",
    "entityaddresspostalzipcode": 59200,
    "entityaddressaddressline3": "8 Jalan Kerinchi",
    "localphonenumber": "1221-26512",
    "entityaddresscountry": "MY",
    "cityareacode": 60,
    "auditorname": "JP CENTURION & PARTNERS PLT",
    "auditorfirmid": 6723,
    "auditorlocation": "Kuala Lumpur, Malaysia",
    "cash": 611849,
    "depositsassets": 1507015,
    "accountsreceivablenet": 2868364,
    "otherreceivables": 25240,
    "incometaxesreceivable": 31551,
    "inventorynet": 977807,
    "assetscurrent": 6021826,
    "operatingleaserightofuseasset": 55730,
    "propertyplantandequipmentnet": 1511708,
    "otherinvestments": 1150898,
    "assetsnoncurrent": 2718336,
    "assets": 8740162,
    "accountspayablecurrent": 1861015,
    "otheraccountspayableandaccruedliabilities": 103370,
    "operatingleaseliabilitycurrent": 16569,
    "customeradvancescurrent": 23123,
    "liabilitiescurrent": 2004077,
    "operatingleaseliabilitynoncurrent": 40206,
    "deferredincometaxliabilitiesnet": 30866,
    "liabilitiesnoncurrent": 71072,
    "liabilities": 2075149,
    "commonstockvalue": 10929574,
    "additionalpaidincapital": -5011891,
    "retainedearningsaccumulateddeficit": 1156392,
    "accumulatedothercomprehensiveincomelossnetoftax": -409062,
    "stockholdersequity": 6665013,
    "liabilitiesandstockholdersequity": 8740162,
    "commonstocksharesauthorized": 300000000,
    "commonstocksharesoutstanding": 173718152,
    "preferredstocksharesauthorized": 30000000,
    "revenues": 10928707,
    "costofrevenue": 9669678,
    "grossprofit": 1259029,
    "otherincome": 179283,
    "generalandadministrativeexpense": 1729489,
    "operatingincomeloss": -291177,
    "financecosts": -12479,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -303656,
    "deferredothertaxexpensebenefit": 3898,
    "incometaxespaid": 48412,
    "incometaxexpensebenefit": -52310,
    "profitloss": -355966,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletoparent": -308800,
    "comprehensiveincomenetoftax": -664766,
    "earningpersharebasicanddiluted": -0.002,
    "weightedaveragenumberofcommonsharesoutstandingbasicanddiluted": 172916782,
    "sharesissued": 173718152,
    "netincomeloss": -355966,
    "foreigncurrencytranslationloss": -308800,
    "stockissuedduringperiodsharesnewissues": 2500000,
    "stockissuedduringperiodvaluenewissues": 150000,
    "financeleaserightofuseassetamortization": 13992,
    "provisionfordoubtfulaccounts": 4165,
    "depreciation": 91427,
    "dividendincome": -115379,
    "fairvalueassetsmeasuredonrecurringbasischangeinunrealizedgainloss": 70628,
    "lossonwrittenoffofotherinvestments": 1776,
    "operatinglossprofitbeforeworkingcapitalchanges": -289357,
    "increasedecreaseininventories": 544108,
    "increasedecreaseinotherreceivables": 538646,
    "increasedecreaseindeferredcostofrevenue": 67606,
    "increasedecreaseinotheraccountspayable": -119695,
    "increasedecreaseincustomeradvances": -7184,
    "increasedecreaseindeferredrevenue": -77276,
    "increasedecreaseinoperatingleaseliability": -126686,
    "increasedecreaseinincometaxesreceivable": 13866,
    "netcashprovidedbyusedinoperatingactivities": 544028,
    "paymentstoacquireotherinvestments": 511706,
    "proceedsfromequitymethodinvestmentdividendsordistributionsreturnofcapital": 115379,
    "paymentstoacquirepropertyplantandequipment": 54171,
    "netcashprovidedbyusedininvestingactivities": -450498,
    "repaymentoffinancelease": -34038,
    "repaymentofsharessubscriptions": 150000,
    "netcashprovidedbyusedinfinancingactivities": 115962,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -214547,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -5055,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 2118864,
    "fixeddepositsplacedwithfinancialinstitutions": 1507015,
    "cashandbankbalances": 611849,
    "cashandcashequivalentsendoffinancialyear": 2118864,
    "interestpaidnet": 12479,
    "incometaxespaidnet": -170447,
    "businessacquisitionpercentageofvotinginterestsacquired": 1,
    "businessacquisitiondescriptionofacquiredentity": "The principal office address is Unit 02 Level 10, Tower B, Vertical Business Suite, No. 8 Jalan Kerinchi, Bangsar South, 59200 Kuala Lumpur, Malaysia, our lab is located at Lab 353, Chemical Science Centre, University Science Malaysia, George Town, Penang, Malaysia. We also have a blood collection center located at 1st floor, Lifecare Medical Centre, Kuala Lumpur, Malaysia",
    "businessacquisitioneffectivedateofacquisition1": "2017-08-23",
    "businessacquisitionequityinterestsissuedorissuablenumberofsharesissued": 68487261,
    "principalannualratesexpectedusefullife": 0.2,
    "yearendusmyrexchangerate": 4.39,
    "yearlyaverageusmyrexchangerate": 4.3996,
    "debtinstrumentinterestrateterms": "The account receivables are non-interest bearing and is generally on 30 days to 90 days term.",
    "taxrecoverable": -31551,
    "deferredtaxliabilities": 30866,
    "incometaxsliability": -685,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.24,
    "additionofrightofuseassets": 32281,
    "accumulatedamortizationoflease": -15534,
    "foreigntranslationdifferences": -2107,
    "operatingleaseliability": 56775,
    "addadditionofleaseliabilities": 30770,
    "operatingleasepayments": 19618,
    "addimputedinterest": 4913,
    "otherliabilitiescurrent": 16569,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 16569,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 17048,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 11209,
    "operatingleasesfutureminimumpaymentsdueinfiveyears": 11949,
    "operatingleasesfutureminimumpaymentsdue": 56775,
    "operatingcashflowfromoperatinglease": -126686,
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 55730,
    "finitelivedintangibleassetusefullife": "P4Y",
    "weightedaveragediscountrateforoperatinglease": 0.064,
    "operatingleaserightofuseassetamortizationexpense": 13992,
    "rentaldiscountrate": 0.064,
    "operatingleaseexpense": 4913,
    "propertyplantandequipmentgross": 1124,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 616913,
    "addforeigntranslationdifferences": -133982,
    "otherinvestmentsbeginningbalance": 749027,
    "additionduringtheyear": 511706,
    "writtenoffduringtheyear": -1776,
    "fairvaluegain": -70628,
    "foreignexchangetranslation": -37431,
    "otherinvestmentseningbalance": 1150898,
    "totalinvestments": 1150898,
    "concentrationriskpurchase": 1497142,
    "concentrationriskpercentage1": 0.1,
    "concentrationofriskaccountspayabletrade": 147376,
    "commonstocksharesissued": 173718152,
    "othergeneralandadministrativeexpense": 286753,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -239229,
    "deferredincometaxexpensebenefit": -2470,
    "incometaxbenefit": -48412
  },
  {
    "date": "2021-12-30",
    "symbol": "BGLC",
    "period": "FY",
    "entityregistrantname": "BIONEXUS GENE LAB CORP",
    "entitycentralindexkey": 1737523,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "December 31, 2021",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2021,
    "entityextransitionperiod": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "333-229399",
    "entityincorporationstatecountrycode": "Wyoming",
    "entitytaxidentificationnumber": "35-2604830",
    "entityaddressaddressline1": "Unit 02, Level 10, Tower B, Avenue 3,The Vertical",
    "entityaddressaddressline2": "Business Suite II,Bangsar South",
    "entityaddressaddressline3": "No. 8 Jalan Kerinchi",
    "entityaddresscityortown": "Kuala Lumpur",
    "entityaddresscountry": "Malaysia",
    "entityaddresspostalzipcode": 59200,
    "cityareacode": 60,
    "auditorname": "JP CENTURION & PARTNERS PLT",
    "auditorlocation": "Kuala Lumpur, Malaysia",
    "auditorfirmid": 6723,
    "localphonenumber": "1221-26512",
    "entityinteractivedatacurrent": "Yes",
    "cash": 578511,
    "depositsassets": "null",
    "tradereceivables": "null",
    "otherreceivables": 79517,
    "deferredcosts": 67606,
    "inventorynet": "null",
    "assetscurrent": "null",
    "operatingleaserightofuseasset": 41090,
    "propertyplantandequipmentnet": "null",
    "otherinvestments": 1875,
    "assetsnoncurrent": "null",
    "assets": "null",
    "accountspayabletradecurrent": "null",
    "otheraccountspayableandaccruedliabilities": 71814,
    "financeleaseliabilitycurrent": 21235,
    "operatingleaseliabilitycurrent": 18272,
    "deferredrevenue": 77276,
    "customeradvancescurrent": 30307,
    "taxespayablecurrentandnoncurrent": 97585,
    "liabilitiescurrent": "null",
    "operatingleaseliabilitynoncurrent": 24637,
    "financeleaseliabilitynoncurrent": 24637,
    "deferredtaxliabilities": 28416,
    "liabilitiesnoncurrent": 65856,
    "liabilities": "null",
    "commonstockvalue": "null",
    "additionalpaidincapital": "-null",
    "retainedearningsaccumulateddeficit": "null",
    "accumulatedothercomprehensiveincomelossnetoftax": -100262,
    "stockholdersequity": -100262,
    "liabilitiesandstockholdersequity": 9574390,
    "preferredstocksharesauthorized": "null",
    "commonstocksharesauthorized": "null",
    "commonstocksharesoutstanding": "null",
    "revenues": "null",
    "costofrevenue": "null",
    "grossprofit": "null",
    "otherincome": 66491,
    "generalandadministrativeexpense": "null",
    "operatingincomeloss": "null",
    "financecosts": -12973,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": "null",
    "deferredincometaxexpensebenefit": -26736,
    "incometaxespaid": 264547,
    "totaltaxexpensecredit": 291283,
    "netincomeloss": 751571,
    "foreigncurrencytransactiongainlossrealized": -233946,
    "comprehensiveincomenetoftax": 517625,
    "earningspersharesbasicanddiluted": 0.003,
    "weightedaveragenumberofsharesoutstandingbasicanddiluted": "null",
    "sharesissued": "null",
    "profitloss": 751571,
    "financeleaserightofuseassetamortization": 16933,
    "cashandcashequivalentsatcarryingvalue": "null",
    "provisionfordoubtfulaccounts": 3809,
    "depreciation": 91282,
    "dividendincomeoperating": 22036,
    "fairvaluegainonotherinvestments": 29850,
    "operatingprofitbeforeworkingcapitalchanges": 871409,
    "increasedecreaseininventories": -345745,
    "increasedecreaseinotherreceivables": 579217,
    "increasedecreaseindeferredcostofrevenue": -67606,
    "increasedecreaseinotheraccountspayable": "-null",
    "increasedecreaseincustomeradvances": 30307,
    "increasedecreaseindeferredrevenue": 77276,
    "increasedecreaseinoperatingliabilities": -20169,
    "increasedecreaseinincometaxesreceivable": 65007,
    "netcashprovidedbyusedinoperatingactivities": 9161,
    "paymentstoacquireotherinvestments": 515840,
    "dividendincome": 22036,
    "paymentstoacquirepropertyplantandequipment": 3162,
    "proceedsfromsaleofinvestmentprojects": 6392,
    "netcashprovidedbyusedininvestingactivities": -490574,
    "repaymentoffinancelease": -26302,
    "repaymentsofrelatedpartydebt": 1920,
    "netcashprovidedbyusedinfinancingactivities": -28222,
    "effectofexchangesrateoncash": -154138,
    "cashperiodsincreasedecrease": -663773,
    "cashequivalentsatcarryingvalue": "null",
    "fixeddepositsplacedwithfinancialinstitutions": "null",
    "cashandbankbalances": 578511,
    "interestpaidnet": 12973,
    "incometaxespaidnet": -226770,
    "businessacquisitionpercentageofvotinginterestsacquired": 1,
    "businessacquisitiondescriptionofacquiredentity": "The principal office address is Unit 02 Level 10, Tower B, Vertical Business Suite, No. 8 Jalan Kerinchi, Bangsar South, 59200 Kuala Lumpur, Malaysia, our lab is located at Lab 353, Chemical Science Centre, University Science Malaysia, George Town, Penang, Malaysia. We also have a blood collection center located at 1st floor, Lifecare Medical Centre, Kuala Lumpur, Malaysia",
    "businessacquisitioneffectivedateofacquisition1": "August 23, 2017",
    "businessacquisitionequityinterestsissuedorissuablenumberofsharesissued": "null",
    "principalannualratesexpectedusefullife": 0.1,
    "periodendus1myrexchangerate": 4.165,
    "yearlyaverageus1myrexchangerate": 4.1456,
    "debtinstrumentinterestrateterms": "The account receivables are non-interest bearing and is generally on 30 days to 90 days term",
    "allowanceforloanandleaselosseswriteoffs": 3809,
    "incometaxliability": 126001,
    "initialrecognitionofoperatingleaseright": 62529,
    "reductionduetodiscountonrental": -913,
    "accumulatedamortizationoflease": -18305,
    "foreigntranslationdifferences": -5046,
    "operatingleaseliabilityinitialrecognition": 63079,
    "discountonrental": -972,
    "operatingleasepayments": 16856,
    "addimputedinterest": 2704,
    "operatingleaseliability": 42909,
    "otherliabilitiescurrent": 18272,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 18272,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 11987,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 12650,
    "lesseeoperatingleaseliabilitypaymentsdue": 42909,
    "operatingcashflowfromoperatinglease": -20169,
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 41090,
    "finitelivedintangibleassetusefullife": 2,
    "weightedaveragediscountrateforoperatinglease": 0.054000000000000006,
    "operatingleaserightofuseassetamortizationexpense": 16933,
    "operatingleaseexpense": 2704,
    "lesseeoperatingleasediscountrate": 0.054000000000000006,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 525631,
    "propertyplantandequipmentgross": "null",
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": -48383,
    "otherinvestmentsbeginningbalance": 281668,
    "additionduringtheyear": 515840,
    "disposalgroupnotdiscontinuedoperationgainlossondisposal": -6392,
    "fairvaluegain": -29850,
    "foreignexchangetranslation": -12239,
    "otherinvestmentseningbalance": 749027,
    "totalinvestments": 747152,
    "financelease": 35254,
    "lessinterestexpense": -1216,
    "netpresentvalueoffinancelease": 34038,
    "financeleaseliabilitynoncurrentportion": 12803,
    "financeleaseliability": 34038,
    "financeleaseliabilitypaymentsdueyearthree": 21235,
    "financeleaseliabilitypaymentsdueyearfour": 12803,
    "totalpurchase": "null",
    "totalpercentagesofpurchases": 0.5772,
    "toatlaccountspayabletrade": "null",
    "purchase": "null",
    "percentagesofpurchases": 0.1068,
    "accountspayabletrade": 269966,
    "concentrationriskpercentage1": 0.1,
    "commonstocksharesissued": "null",
    "othergeneralandadministrativeexpense": "null",
    "incometaxexpensebenefit": -264547,
    "deferredincometaxesandtaxcredits": -291283
  },
  {
    "date": "2020-12-30",
    "symbol": "BGLC",
    "period": "FY",
    "entityregistrantname": "BioNexus Gene Lab Corp",
    "entitycentralindexkey": 1737523,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "2020-12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2020,
    "entityextransitionperiod": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes",
    "cash": 699585,
    "depositsassets": 2088107,
    "tradereceivables": 3996802,
    "otherreceivables": 4420112,
    "incometaxesreceivable": 2190,
    "inventorynet": 1315627,
    "assetscurrent": 7985494,
    "operatingleaserightofuseasset": 62529,
    "propertyplantandequipmentnet": 4294905,
    "otherinvestments": 147882,
    "assetsnoncurrent": 2129799,
    "assets": 10115293,
    "accountspayabletradecurrent": 3170653,
    "otheraccountspayableandaccruedliabilities": 95882,
    "financeleaseliabilitycurrent": 25048,
    "operatingleaseliabilitycurrent": 20702,
    "taxespayablecurrentandnoncurrent": 61313,
    "liabilitiescurrent": 3373598,
    "operatingleaseliabilitynoncurrent": 42377,
    "financeleaseliabilitynoncurrent": 35292,
    "deferredtaxliabilities": 1872,
    "liabilitiesnoncurrent": 79541,
    "liabilities": 3453139,
    "commonstockvalue": 10779574,
    "additionalpaidincapital": -5011891,
    "retainedearningsaccumulateddeficit": 760787,
    "accumulatedothercomprehensiveincomelossnetoftax": 133684,
    "stockholdersequity": 133684,
    "liabilitiesandstockholdersequity": 10115293,
    "preferredstocksharesauthorized": 30000000,
    "commonstocksharesauthorized": 300000000,
    "commonstocksharesoutstanding": 171218152,
    "revenues": 11390440,
    "costofrevenue": 9670617,
    "grossprofit": 1719823,
    "otherincome": 886942,
    "generalandadministrativeexpense": 1332943,
    "operatingincomeloss": 1273822,
    "financecosts": 11313,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": 1262509,
    "deferredincometaxexpensebenefit": -1238,
    "incometaxespaid": 169649,
    "totaltaxexpensecredit": -168411,
    "netincomeloss": 1094098,
    "foreigncurrencytransactiongainlossrealized": 150787,
    "comprehensiveincomenetoftax": 1244885,
    "earningspersharebasicanddiluted": 0.012,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 102918015,
    "sharesissued": 171218152,
    "stockissuedduringperiodsharesnewissues": 68487261,
    "stockissuedduringperiodvaluenewissues": 4294905,
    "profitloss": 1094098,
    "foreigncurrencytranslationgain": 150787,
    "financeleaserightofuseassetamortization": 10816,
    "provisionfordoubtfulaccounts": 2658,
    "depreciation": 90787,
    "dividendincome": 6310,
    "fairvaluegainonotherinvestments": -38742,
    "gainlossoninvestments": 3965,
    "propertyplantandequipmentdisposals": -706953,
    "operatingprofitlossbeforeworkingcapitalchanges": 450319,
    "increasedecreaseininventories": 147038,
    "increasedecreaseinotherreceivables": 411069,
    "increasedecreaseinotheraccountspayable": -524240,
    "proceedsfromleasepayments": 38931,
    "increasedecreaseinincometaxesreceivable": 29563,
    "netcashprovidedbyusedinoperatingactivities": 552680,
    "paymentstoacquireotherinvestments": 108631,
    "investmentincomeinterestanddividend": -6310,
    "netcashfromacquisitionofbusinessundercommoncontrol": 346008,
    "paymentstoacquirepropertyplantandequipment": 421621,
    "proceedsfromsaleofinvestmentprojects": 30059,
    "proceedsfromsaleofpropertyplantandequipment": 1467865,
    "netcashprovidedbyusedininvestingactivities": 1319990,
    "repaymentoffinancelease": -4947,
    "netcashprovidedbyusedinfinancingactivities": -4947,
    "effectofexchangerateoncash": 60893,
    "cashperiodincreasedecrease": 1928616,
    "cashandcashequivalentsatcarryingvalue": 2787692,
    "fixeddepositsplacedwithfinancialinstitutions": 2088107,
    "cashandcashequivalentsendoffinancialyear": 2787692,
    "interestpaidnet": -11313,
    "incometaxrefunded": 11697,
    "incometaxespaidnet": -143496,
    "businessacquisitionpercentageofvotinginterestsacquired": 1,
    "businessacquisitioneffectivedateofacquisition1": "2017-08-23",
    "businessacquisitiondescriptionofacquiredentity": "The principal office address is Unit 02 Level 10, Tower B, Vertical Business Suite, No. 8 Jalan Kerinchi, Bangsar South, 59200 Kuala Lumpur, Malaysia, our lab is located at Lab 353, Chemical Science Centre, University Science Malaysia, George Town, Penang, Malaysia. ",
    "businessacquisitionequityinterestsissuedorissuablenumberofsharesissued": 68487261,
    "principalannualratesexpectedusefullife": 0.1,
    "periodendus1myrexchangerate": 4.017,
    "sixmonthsaverageus1myrexchangerate": 4.201,
    "beddebtswrittenoff": 2658,
    "debtinstrumentinterestrateterms": "The account receivables are non-interest bearing and is generally on 30 days to 90 days term. ",
    "taxrecoverable": -2190,
    "incometaxliability": 60995,
    "initialrecognitionofoperatingleaseright": 23542,
    "addadditionofrightofuseassets": 61128,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 441541,
    "foreigntranslationdifferences": 459,
    "operatingleaseliabilityinitialrecognition": 24148,
    "addadditionofleaseliabilities": 61128,
    "operatingleasepayments": -26036,
    "addimputedinterest": 3380,
    "operatingleaseliability": 63079,
    "otherliabilitiescurrent": -20702,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 20702,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 18945,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 12428,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 11004,
    "lesseeoperatingleaseliabilitypaymentsremainderoffiscalyear": 63079,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 65529,
    "remainingleasetermforoperatingleaseyears": "P4Y",
    "operatingleaseweightedaveragediscountratepercent": 0.054,
    "discountrate": "Discount rate of 5.40% per annum ",
    "operatingleaseexpense": 61128,
    "propertyplantandequipmentgross": 1878073,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": 21874,
    "gainlossonsaleofpropertyplantequipment": 706953,
    "transferredofpropertyundercommoncontroltransaction": 1878073,
    "otherinvestmentsbeginningbalance": 12215,
    "businesscombinationconsiderationtransferred1": 147882,
    "additionduringtheyear": 108631,
    "disposalgroupnotdiscontinuedoperationgainlossondisposal": -34923,
    "gainonfairvaluehedgeineffectiveness": 38742,
    "foreignexchangetranslation": 9121,
    "otherinvestmentseningbalance": 281668,
    "financelease": 63703,
    "lessinterestexpense": -3363,
    "netpresentvalueoffinancelease": 60340,
    "financeleaseliability": -7170,
    "financeleaseliabilitypaymentsdueyeartwo": 25048,
    "financeleaseliabilitypaymentsdueyearthree": 22017,
    "financeleaseliabilitypaymentsdueyearfour": 13275,
    "interestrateannually": 0.057,
    "purchaseobligation": 1319232,
    "percentageofcostofsales": 0.14,
    "accountspayableothercurrent": -3771339,
    "cashequivalentsatcarryingvalue": 346008,
    "taxespayablecurrent": -34288,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedassets": 4294905,
    "netcashtransferred": 346008,
    "commonstocksharesissued": 171218152,
    "operatingexpenses": 1332943,
    "incometaxexpensebenefit": -168411
  },
  {
    "date": "2019-12-30",
    "symbol": "BGLC",
    "period": "FY",
    "entityregistrantname": "BioNexus Gene Lab Coporation",
    "entitycentralindexkey": 1737523,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "2019-12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2019,
    "entityextransitionperiod": "false",
    "entityfilenumber": "333-229399",
    "entityaddressaddressline1": "Unit 02, Level 10, Tower B, Avenue 3, The Vertical Business Suite II,",
    "entityaddressaddressline2": "Bangar South No. 8 Jalan Kerinchi",
    "entityaddresspostalzipcode": 59200,
    "entitytaxidentificationnumber": 352604830,
    "entityaddresscityortown": "Kuala Lumpur",
    "localphonenumber": "1221-26512",
    "cityareacode": 60,
    "entityaddressstateorprovince": "MALAYSIA",
    "cash": 366038,
    "depositsassets": 493038,
    "otherreceivables": 13057,
    "incometaxesreceivable": 2858,
    "inventorynet": 7580,
    "assetscurrent": 882571,
    "operatingleaserightofuseasset": 23542,
    "propertyplantandequipmentnet": 312908,
    "otherinvestments": 12215,
    "assetsnoncurrent": 348665,
    "assets": 1231236,
    "otheraccountspayableandaccruedliabilities": 19437,
    "financeleaseliabilitycurrent": 20201,
    "operatingleaseliabilitycurrent": -11936,
    "liabilitiescurrent": 51574,
    "operatingleaseliabilitynoncurrent": 12212,
    "financeleaseliabilitynoncurrent": 45086,
    "liabilitiesnoncurrent": 57298,
    "liabilities": 108872,
    "commonstockvalue": 6484669,
    "additionalpaidincapital": -5011891,
    "retainedearningsaccumulateddeficit": -333311,
    "accumulatedothercomprehensiveincomelossnetoftax": -17103,
    "stockholdersequity": -17103,
    "liabilitiesandstockholdersequity": 1231236,
    "commonstocksharesauthorized": 300000000,
    "commonstocksharesoutstanding": 102730891,
    "preferredstocksharesauthorized": 300000000,
    "revenues": 126955,
    "costofrevenue": -71067,
    "grossprofit": 55888,
    "otherincome": 25048,
    "generalandadministrativeexpense": -356641,
    "operatingincomeloss": -275705,
    "deferredincometaxexpensebenefit": 4477,
    "incometaxexpensebenefit": 24759,
    "othernonoperatingincomeexpense": 29236,
    "netincomeloss": -246469,
    "goodwillforeigncurrencytranslationgainloss": 9874,
    "comprehensiveincomenetoftax": -236595,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 86369145,
    "sharesissued": 102730891,
    "issuedsharesamount": 30033,
    "issuedsharesshares": 30033333,
    "profitloss": -246469,
    "cancellationofsharesamount": -193000,
    "foreigncurrencytranslationgain": 9874,
    "cancellationofsharesshares": -1930000,
    "depreciationandamortization": 41714,
    "financeleaserightofuseassetamortization": 11618,
    "operatinglossprofitbeforeworkingcapitalchanges": -193137,
    "increasedecreaseininventories": 7721,
    "increasedecreaseinothercurrentassets": 9758,
    "increasedecreaseinotheraccountspayable": -30603,
    "increasedecreaseinoperatingleaseliability": -11012,
    "netcashprovidedbyusedinoperatingactivities": -217273,
    "paymentstoacquirepropertyplantandequipment": -12817,
    "netcashprovidedbyusedininvestingactivities": -12817,
    "repaymentsofdebt": -16777,
    "proceedsfromrepaymentsofrelatedpartydebt": -1061,
    "proceedsfromissuanceofcommonstock": -162967,
    "netcashprovidedbyusedinfinancingactivities": -180805,
    "othercomprehensiveincomeforeigncurrencytranslationadjustmenttaxportionattributabletoparent": 9732,
    "cashperiodincreasedecrease": -401163,
    "cashandcashequivalentsbeginningoffinancialyear": 1260239,
    "cashandcashequivalentsendoffinancialyear": 859076,
    "fixeddepositsplacedwithfinancialinstitutions": 493038,
    "cashatbank": 366038,
    "cashandcashequivalentendoffinancialyear": 859076,
    "interestpaidnet": -5047,
    "incometaxespaid": -10714,
    "statecountryname": "Wyoming",
    "entityincorporationdateofincorporation": "2017-05-12",
    "businessacquisitionpercentageofvotinginterestsacquired": 1,
    "businessacquisitioneffectivedateofacquisition1": "2017-08-23",
    "businessacquisitionbusinessoperationdescription": "The principal office address is Unit 02 Level 10, Tower B, Vertical Business Suite, No. 8 Jalan Kerinchi, Bangsar South, 59200 Kuala Lumpur, Malaysia, our lab is located at Lab 353, Chemical Science Centre, University Science Malaysia, George Town, Penang, Malaysia. We also have a blood collection center located at 1st floor, Lifecare Medical Centre, Kuala Lumpur, Malaysia.  ",
    "principalannualratesexpectedusefullife": 0.2,
    "yearlyaveragemyrexchangerate": 4.141,
    "yearendmyrexchangerate": 4.0925,
    "effectiveincometaxratecontinuingoperations": 0.5,
    "leasepaymentexceedingfairvalue": 0.9,
    "leasetermpercentage": 0.75,
    "commonstocksharesissued": 102730891,
    "propertyplantandequipmentgross": 2916,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 11771,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": 6136,
    "depreciation": 41714,
    "financelease": 69863,
    "lessinterestexpense": -4576,
    "netpresentvalueoffinancelease": 65287,
    "financeleaseliability": 65287,
    "financeleaseliabilitypaymentsdueyeartwo": 21138,
    "financeleaseliabilitypaymentsdueyearthree": 23948,
    "interestrateannually": 0.0599,
    "expirationdate": "January 2023",
    "initialrecognitionofoperatingleaseright": 35313,
    "endingbalanceoperatingleaseright": 23542,
    "leaserepayment": -13192,
    "addimputedinterest": 2027,
    "operatingleaseliability": 24148,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 11936,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 12212,
    "operatingleasesfutureminimumpaymentsdue": 24148,
    "operatingcashflowfromoperatinglease": 11012,
    "rightofuseassetsobtainedinexchangeforoperatingleaseliabilities": 23542,
    "remainingleasetermforoperatingleaseyears": "P2Y",
    "weightedaveragediscountrateforoperatinglease": 0.067,
    "operatingleaseexpense": 2001,
    "taxrecoverable": -2858,
    "incometaxliability": -2858,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.24,
    "relatedpartya": 30033,
    "totallistingexpense": 30033,
    "equitymethodinvestmentownershippercentage": 0.2923
  }
]